---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-003575"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2023-02-16T23:59:59+00:00"
generated_at: "2026-06-19T09:53:26.909167+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NRC Health reports Q4 EPS $0.27, down from $0.38; FY revenue +7% but EPS $1.27 vs $1.46

## Summary
- Q4 diluted EPS $0.27 (vs $0.38 in Q4 2021); full-year 2022 diluted EPS $1.27 (vs $1.46).
- FY 2022 revenue grew 7% year-over-year driven by core Human Understanding Program; Canadian ops phase-out partially offset.
- $2.6M reclassification from substantial liquidation of Canadian subsidiary impacted other expense.
- Capital allocation: $21.0M dividends, $27.6M share repurchases, $12.2M innovation/growth in 2022.
- New client wins including St. Bernards Healthcare; received Best in KLAS 2023 Award for Patient Experience Improvement.

## SEC filing metadata
- accession: 0001437749-23-003575
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2023-02-16T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774923003575/0001437749-23-003575-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774923003575/nrc20230215_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-003575
- JSON: https://secwatch.observer/filing/0001437749-23-003575.json
- Plain text: https://secwatch.observer/filing/0001437749-23-003575.txt

## Key facts
- Earnings Releases
  NRC HEALTH reported financial results for fourth quarter and year ended December 31, 2022.
  - Period: fourth quarter and year ended December 31, 2022
  - Result: reported results
  source text: On February 14, 2023, National Research Corporation, a Delaware corporation (the "Company"), issued a press release announcing its financial and operating results for the fourth quarter and year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/70487/000143774923003575/0001437749-23-003575-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.